The use of next-generation sequencing in pharmacogenomics. Clin Lab 2023;69(8).
Comparison of cycle-threshold-values between two commercial SARS-CoV-2 PCR assays. EXCLI J 2023;22:397-399.
Publizierte wissenschaftliche Arbeiten bis 2022
2023
Fecal calprotectin elevations associated with food intolerance/malabsorption are significantly reduced with targeted diets. Nutrients 2023;15(5):1179.Â
2022
Schnedl WJ, Meier-Allard N, Michaelis S, Lackner S, Enko D, Mangge H, Holasek SJ. Serum Diamine Oxidase Values, Indicating Histamine Intolerance, Influence Lactose Tolerance Breath Test Results. Nutrients 2022; 14(10):2026.
Schnedl WJ, Meier-Allard N, Schenk M, Lackner S, Enko D, Mangge H, Holasek S J. Helicobacter pylori infection and lactose intolerance increase expiratory hydrogen. EXCLI J 2022; 21, 426-435.
Michaelis S, Zelzer S, Schnedl WJ, Baranyi A, Meinitzer A, Enko D. Assessment of tryptophan and kynurenine as prognostic markers in patients with SARS-CoV-2. Clin Chim Acta 2022;525:29-33.
2021
Schnedl W, Nahrungsmittelintoleranzen. Malabsorption: Kombiniertes Auftreten. Österreichische Ärztezeitung 2021, 17/10: 67-68.
Mangge H, Kneihsl M, Schnedl W, Sendlhofer G, Curcio F, Domenis R. Immune Responses against SARS-CoV-2-Questions and Experiences. Biomedicines 2021;9(10):1342.
Schnedl WJ, Enko D. Histamine intolerance origins in the gut. Nutrients 2021, 13:Â 1262.
Lafer I, Michaelis S, Schneider C, Baranyi A, Schnedl WJ, Holasek S, Zelzer S, Niedrist T, Meinitzer A, Enko D. Beta-trace protein concentrations at the blood-cerebrospinal fluid barrier – acute phase affects protein status. EXCLI J 2021;20:1446-1452.
Schnedl WJ, Holasek SJ, Schenk M, Enko D, Mangge H. Diagnosis of hepatic nuclear factor 1A monogenic diabetes mellitus (HNF1A-MODY) impacts antihyperglycemic treatment. Wien Klin Wochenschr 2021; 133: 241-244.
Schnedl WJ, Mangge H, Schenk M, Enko D. Non-responsive celiac disease may coincide with additional food intolerance/malabsorption, including histamine intolerance Med Hypotheses 2021; 110404.
2020
Schnedl WJ, Meier-Allard N, Lackner S, Enko D, Mangge H, Holasek SJ. Increasing expiratory hydrogen in lactose intolerance is associated with additional food intolerance/malabsorption. Nutrients 2020;12: 3690.
Enko D, Moro1 T, Holasek S, Baranyi A, Schnedl WJ, Zelzer S, Mangge H, Herrmann M, Meinitzer A. Branched-chain amino acids are linked with iron metabolism. Ann Transl Med 2020, 23:1569.Â
Enko D, Stelzer I, Böckl M, Schnedl WJ, Meinitzer A, Herrmann M, Tötsch M, Gehrer M. Comparison of the reliability of Gram-negative and Gram-positive flags of the Sysmex UF-5000 with manual Gram stain and urine culture results. Clin Chem Lab Med. 2020; 59: 619-624.
Schnedl WJ, Schenk M, Enko D, Mangge H. Severe rhabdomyolysis in homozygote carnitine palmitoyltransferase II deficiency. EXCLI J. 2020;19:1309-1313.
Enko D, Zelzer S, Niedrist T, Holasek S, Baranyi A, Schnedl WJ, Herrmann M, Meinitzer A. Assessment of trimethylamine-N-oxide at the blood-cerebrospinal fluid barrier: Results from 290 lumbar punctures. EXCLI J. 2020;19:1275-1281.
Schnedl WJ, Enko D. Considering histamine in functional abdominal complaints. Crit Rev Food Sci Nutr. 2020; 1-8.
Enko D, Herrmann M, Baranyi A, Schnedl WJ, Halwachs-Baumann G. Long time blood-transfusion trend in a European general hospital. EXCLI J. 2020; 19: 855-860.Â
Mangge H, PrĂĽller F, Schnedl W, Renner W, Almer G. Beyond macrophages and T cells: B bells and immunoglobulins determine the fate of the atherosclerotic plaque. Intern J Mol Sci, 2020; 21: 4082.
Schnedl WJ, Tillich M, Schenk M, Enko D, Mangge H. Food intolerance/malabsorption may occur in rare diseases. Intractable Rare Dis Res, 2020; 9: 126-129.
Meinitzer S, Baranyi A, Holasek S, Schnedl WJ, Zelzer S, Mangge H, Herrmann M, Meinitzer A, Enko D. Sex-specific associations of trimethylamine-N-oxide and zonulin with signs of depression in carbohydrate malabsorbers and nonmalabsorbers. Dis Markers, 2020; 7897240.
2019
Enko D, Stelzer I, Böckl M, Derler B, Schnedl WJ, Anderssohn P, Meinitzer A, Herrmann M. Comparison of the diagnostic performance of two automated urine sediment analyzers with manual phase-contrast microscopy. Clin Chem Lab Med, 2019; in press.
Wenninger J, Meinitzer A, Holasek S, Schnedl WJ, ZelzerS, Mangge H, Herrmann M, Enko D. Associations between tryptophan and iron metabolism observed in individuals with and without iron deficiency. Sci Rep 2019; 9: 14548.
Schnedl WJ, Reittner P, Enko D, Mangge H. Food malabsorption/intolerance complaints triggered by primary epiploic appendagitis. EXCLI J 2019; 18: 746-749
Schnedl WJ, Queissner R, Schenk M, Enko D, Mangge H. Hereditary methemoglobinemia caused by Hb M-Hyde Park and Hb M-Akita (HBB:c.277C>T; p.His93Tyr). Wien Klin Wochenschr 2019; 131: 381-384
Schnedl WJ, Queissner R. Migraines appear more likely to be caused by histamine rather than ethanol. Europ J Neurol 2019; 26: e79
Schnedl WJ, Schenk M, Lackner S, Enko D, Mangge H, Forstner F. Diamine oxidase supplementation improves symptoms in patients with histamine intolerance. Food Sci Biotechnol 2019; 28: 1779–1784
Schnedl WJ, Lackner S, Enko D, Schenk M, Holasek SJ, Mangge H. Evaluation of symptoms and symptom combinations in histamine intolerance. Intest Res 2019; 17: 427-433
Enko D, Wagner H, Kriegshäuser G, Wögerer J, Halwachs-Baumann G, Schnedl WJ, Zelzer S, Fauler G, Mangge H, Herrmann M, Meinitzer A. Iron status determination in individuals with Helicobacter pylori infection: conventional vs. new laboratory biomarkers. Clin Chem Lab Med 2019; 57: 982–989
Lackner S, Malcher V, Enko D, Mangge H, Holasek S, Schnedl WJ. Histamine-reduced diet and increase of serum diamine oxidase correlating to diet compliance in histamine intolerance. Europ J Clin Nutr 2019, 73:102-104.
2018
Enko D, Meinitzer A, Brandmayer W, Halwachs-Baumann G, Schnedl WJ, Kriegshäuser G. Association between increased plasma levels of homocysteine and depression observed in individuals with primary lactose malabsorption. PLoS One 2018 13:e0202567.
Enko D, Brandmayr W, Halwachs-Baumann G, Schnedl WJ, Meinitzer A, Kriegshäuser G. Prospective plasma lipid profiling in individuals with and without depression. Lipids Health Dis 2018, 17:149
Enko D, Wagner H, Kriegshäuser G, Brandmayr W, Halwachs-Baumann G, Schnedl WJ, Zelzer S, Mangge H, Meinitzer A. Assessment of tryptophan metabolism and signs of depression in individuals with carbohydrate malabsorption. Psychiatry Res 2018, 262:595–599.
Schnedl WJ, Lackner S, Enko D, Schenk M, Mangge H, Holasek SJ. Non-celiac gluten sensitivity. People without celiac disease avoiding gluten – Is it due to histamine intolerance? Inflamm Res 2018, 67:279-284
Schnedl WJ, Schenk M. Das polyzystische Ovar-Syndrom und Metformin. J Gynäkolog Endokrinol 2018, 28: 10-13
2017
Schnedl WJ, Schenk M, Lackner S, Holasek SJ, Mangge H. β-thalassemia minor, carbohydrate malabsorption and histamine intolerance. J Comm Hosp Int Med Persp 2017, 7:227-229.
Schnedl WJ. Gleichzeitige Prävalenz von niedriger Serum-Diaminoxidase-Aktivität und Kohlenhydrat- Malabsorption. Gastro & Hepa News 2017, 10: 13-15.
Schnedl WJ, Enko D, Mangge H, Schenk M, Lackner S, Holasek SJ. Bening pancreatic hyperenzymemia (Gullo syndrome), histamine intolerance, and carbohydrate malabsorption. Proc (Bayl Univ Med Cent) 2017, 30: 177-78.
Schnedl WJ, Enko D, Wallner-Liebmann SJ, Lackner S, Mangge H. Dissimilar pain of primary epiploic appendagitis and malabsorption. J Clin Diagn Res 2017, 11: OD14-OD15
Enko D, Kriegshäuser G, Halwachs-Baumann G, Mangge H, Schnedl WJ. Serum diamine oxidase activity is associated with lactose malabsorption phenotypic variation. Clin Biochem 2017, 50: 50-53
2016
Enko D, Meinitzer A, Mangge H, Kriegshäuser G, Halwachs-Baumann G, Reininghaus EZ, Bengesser SA, Schnedl WJ. Concomitant prevalence of low serum diamine oxidase activity and carbohydrate malabsorption. Can J Gastroenterol Hepatol 2016; 2016: 4893501
Zelzer S, PrĂĽller F, Schnedl WJ, Weghuber D, Enko D, Bergsten P, Haybaeck J, Meinitzer A. Branched chain amino acids indicate cardio metabolic risk independent of body mass index. J Nutr Biochem 2016; 32: 123-127
Kaimbacher PS, Wallner-Liebmann SJ, Dunitz-Scheer M, Scheer PJ, Cvirn G, Schrabmair W, Greilberger J, Schnedl WJ, Tafeit E. Significant decrease of subcutaneous body fat during tube-weaning from enteral feeding. Minerva Pediatr 2016, 68: 50-60
Schnedl WJ, Kalmar P, Wallner-Liebmann SJ, Reiter G, Mangge H, Lipp RW. Anomaly of the inferior vena cava and lactose malabsorption. Phlebologie 2016, 45: 35-39
Schnedl W. Histaminintoleranz. Arzt + Patient 2016, 1: 30-32
2015
Kaimbacher PS, Wallner-Liebmann SJ, Dunitz-Scheer M, Scheer PJZ, Cvirn G, Schrabmair W, Schnedl WJ, Hamlin MJ, Tafeit E. Subcutaneous adipose tissue topography in long-term enterally fed children and healthy controls. Coll Antropol 2015, 39: 601-609Â
Mangge H, Baumgartner B, Schnedl W. Letter: PNPLA3, metabolic syndrome and NAFLD status in obese subjects – authors‘ reply. Aliment Pharmacol Therap 2015, 42:Â 630-1
Mangge H, Baumgartner BG, Zelzer S, Prüller F, Schnedl WJ, Reininghaus EZ, Haybäck J, Lackner C, Stauber R, Aigner E, Weghuber D. Patatin-like phospholipase 3 (rs738409) gene polymorphism is associated with increased liver enzymes in obese juveniles and metabolic syndrome in all ages. Aliment Pharmacol Therap 2015, 42: 99-105
Schnedl WJ, Kalmar P, Mangge H, Krause R, Wallner-Liebmann SJ. Co-occurrence of carbohydrate malabsorption and primary epiploic appendagitis. World J Gastroenterol 2015, 21: 10242-54
Schnedl W. Histaminintoleranz. Arzt & Praxis 2015, 69: 75-77
Mangge H, Zelzer S, Meinitzer A, Stelzer I, Schnedl WJ, Weghuber D, Fuchs D, Postolache TT, Aigner E, Datz C, Reininghaus EZ. 25OH-vitamin D3 levels in obesity and metabolic syndrome-unaltered in young and not correlated to carotid IMT in all ages. Curr Pharm Des 2015: 21: 2243-9
2014
Schnedl WJ, Lipp RW, Wallner-Liebmann S, Kalmar P, Szolar DH, Mangge H. Primary epiploic appendagitis and fructose intolerance. Europ J Clin Nutr 2014, 68: 1359-61
Schnedl W. Diabetes mellitus Typ 1. Arzt & Praxis 2014, 68: 149-152
Mangge H, Weghuber D, Prassl R, Haara A, Schnedl W, Postolache TT, Fuchs D. The role of vitamin D in atherosclerosis inflammation revisited: More a bystander than a player? Curr Vasc Pharmacol 2014, 13: 392-8
2013
Kruschitz R, Wallner-Liebmann SJ, Hamlin MJ, Moser M, Ludvik B, Schnedl WJ, Tafeit E. Detecting body fat – a weighty problem BMI versus subcutaneous fat patterns in athletes and non-athletes. PLoS One 2013, 26;8: e72002
Wallner-Liebmann SJ, Kruschitz R, HĂĽbler K, Hamlin MJ, Schnedl WJ, Moser M, Tafeit E. A measure of obesity: BMI versus subcutaneous fat patterns in young athletes and nonathletes. Coll Antropol 2013, 37: 351-357
Mangge H, Schnedl WJ, Schröcksnadel S, Geisler S, Murr C, Fuchs D. Immune activation and inflammation in patients with cardiovascular disease are associated with elevated phenylalanine-to-tyrosine ratios. Pteridines 2013, 24: 51-55
Mangge H, Summers KL, Meinitzer A, Zelzer S, Almer G, Prassl R, Schnedl WJ, Reininghaus E, Paulmichl K, Weghuber D, Fuchs D. Obesity-related dysregulation of the tryptophan-kynurenine metabolism: Role of age and parameters of the metabolic syndrome. Obesity 2013, 22: 195-201
Weghuber D, Zelzer S, Stelzer I, Paulmichl K, Kammerhofer D, Schnedl W, Molnar D, Mangge H. High risk vs. „metabolically healthy“ phenotype in juvenile obesity – neck subcutaneous adipose tissue and serum uric acid are clinically relevant. Exp Clin Endocrinol Diabetes 2013, 121: 384-390
Mangge H, Summers K, Almer G, Prassl R, Weghuber D, Schnedl W, Fuchs D. Antioxidant food supplements and obesity-related inflammation. Curr Med Chem 2013 , 20: 2330-2337
Schnedl WJ, Mirzaei S, Wallner-Liebmann S, Tafeit E, Mangge H, Krause R, Lipp RW. Improvement of cerebral hypoperfusion with levothyroxine therapy in Hashimoto`s encephalopathy demonstrated by 99mTc-HMPAO-SPECT. Europ Thyroid J 2013, 2: 116-119
Schnedl W. 100 Jahre Hashimoto Thyreoiditis (chronische SchilddrĂĽsenentzĂĽndung). Arzt & Praxis 2013, 67: 12-14
Wallner-Liebmann S, Moeller R, Horejsi R, Jürimäe T, Jürimäe J, Mästu J, Purge P, Saar M, Tafeit E, Kaimbacher P, Kruschitz R, Weghuber D, Schnedl WJ, Mangge H. Normal weight Estonian prepubertal boys show a more cardiovascular-risk-associated adipose tissue distribution than Austrian counterparts. ISNR Obesity 2013, : 506751
Mangge H, Zelzer S, Puerstner P, Schnedl WJ, Reeves G, Postolache TT, Weghuber D. Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults. Obesity 2013, 21: E71-77
2012
Theiler G, Langer-Wegscheider B, Zollner-Schwetz I, Valentin T, Hönigl M, Schnedl W, Krause R. Blurred vision and myopic shift in Puumala virus infections are independent of disease severity. Clin Microbiol Infect 2012, 18: E435-437
Schnedl WJ, Krause R, Wallner-Liebmann SJ, Tafeit E, Mangge H, Tillich M. Primary epiploic appendagitis and successful outpatient management. Med Sci Monit 2012, 18: CS48-51
Stelzer I, Zelzer S, Raggam RB, Prüller F, Truschnig-Wilders M, Meinitzer A, Schnedl WJ, Horejsi R, Möller R, Weghuber D, Reeves G, Postolache TT, Mangge H. Link between leptin and interleukin-6 levels in the initial phase of obesity related inflammation. Transl Res 2012, 159: 118-124
Prüller F, Raggam R, Posch V, Almer G, Truschnig-Wilders M, Horejsi R, Möller R, Weghuber D, Ille R, Schnedl W, Mangge H. Trunk weighted obesity, cholesterol levels and low grade inflammation are main determinants for enhanced thrombin generation. Atherosclerosis 2012, 220: 215-218
2011
Zelzer S, Fuchs N, Almer G, Raggam RB, Prüller F, Truschnig-Wilders M, Schnedl W, Horejsi R, Möller R, Weghuber D, Ille R, Mangge H. High density lipoprotein cholesterol level is a robust predictor of lipid peroxidation irrespective of gender, age, obesity, and inflammatory or metabolic biomarkers. Clin Chim Acta 2011, 412: 1345-1349
Mangge H, Almer G, Zelzer S, Vasan R, Kraigher-Krainer E, Gasser R, Schnedl W, Ille R, Wallner S, Möller R, Horejsi R, Weghuber D. N-terminal pro-B-type natriuretic peptide in early and advanced phases of obesity. Clin Chem Lab Med 2011, 49: 1539-46
Schnedl W: Diabetes mellitus und Osteoporose. Arzt & Praxis 2011, 65: 330-33
Kaimbacher PS, Dunitz-Scheer M, Wallner-Liebmann SJ, Scheer PJZ, Sudi K, Schnedl WJ, Tafeit E. Decrease of total subcutaneous adipose tissue from infancy to childhood. J Ped Gastoenterol Nutr 2011, 53: 553-560
Schnedl WJ, Krause R, Tafeit E, Tillich M, Lipp RW, Wallner-Liebmann SJ: Insights into epiploic appendagitis. Nat Rev Gastroenterol Hepatol 2011, 8: 45-49
Hoenigl M, Zollner-Schwetz I, Sill H, Linkesch W, Lass-Flörl C, Schnedl WJ, Krause R: Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haemotological malignancies. Mycoses 2011, 54: 454-459
2010
Schnedl WJ: Vitamin D und Diabetes mellitus. Arzt & Praxis 2010, 64: 228-229
Schnedl WJ, Tillich M, Lipp RW: Image of the month. Primary epiploic appendagitis. Clin Gastroenterol Hepatol 2010 ,8: A16
Schnedl WJ, Reittner P, Krause R, Lipp RW, Tafeit E, Wallner-Liebmann S: Patent abdominal subcutaneous veins caused by congenital absence of the inferior vena cava. J Med Case Rep 2010, 4: 223
2009
Tafeit E, Greiberger J, Cvirn G, Lipp RW, Schnedl WJ, Jurimae J, Wallner-Liebmann SJ. Estimating DXA total body fat percentage by Lipometer subcutaneous adipose tissue thiknesses. Collegicum Antropol 2009, 33: 391-396
Schnedl WJ, Krause R, Tafeit E, Wallner SJ: Autoimmune hepatitis and motor axonal neuropathy. Digestion 2009, 80: 50-51
Schnedl WJ, Piswanger-Soelkner C, Wallner SJ, Krause R, Lipp RW: Agenesis of the dorsal pancreas. Diabet Med 2009, 26: 110 – 114
Schnedl WJ, Piswanger-Sölkner C, Wallner SJ, Reittner P, Krause R, Lipp RW, Hohmeier HE: Agenesis of the dorsal pancreas and associated diseases. Dig Dis Sci 2009, 54: 481-487
Schnedl WJ: Das glykierte Hämoglobin (A1C) zur Diagnose bei Diabetes mellitus. Arzt & Praxis 2009, 63 (995a): 4-6
Schnedl WJ, Piswanger-Soelkner C, Wallner SJ, Krause R, Lipp RW: Agenesis of the dorsal pancreas. World J Gastroenterol 2009, 15 : 376 – 379
2008
Tafeit E, Horejsi R, Pieber TR, Roller RE, Schnedl WJ, Wallner SJ, Jurimae T, Moller R: Subcutaneous fat patterns in type-2 diabetic men and healthy controls. Collegicum Antropol 2008, 32: 607-614
Wallner SJ, Horejsi R, Zweicker R, Watzinger N, Möller R, Schnedl WJ, Schauenstein K, Tafeit E: ROC analysis of subcutaneous adipose tissue topography (SAT-Top) in female coronary heart disease patients and healthy controls. J Physiol Anthropol 2008, 27: 185-191
Schnedl WJ, Krause R, Wallner SJ, Piswanger-Soelkner C, Lipp RW: Effect of silent hemoglobin variants on A1C measurement with the IFCC reference method and 6 routine methods. Clin Chim Acta 2008, 398: 161-162
Piswanger-Sölkner C, Schnedl W: Sekundäre Osteoporose: Diagnose und Therapie. Top-Medizin 2008, 17: 6-8
Piswanger-Sölkner C, Schnedl W: Sekundäre Osteoporose: Diagnose und Therapie. Urologik 2008,15: 42- 43
Wallner SJ, Lothaller H, Liebmann PM, Schnedl WJ, Wascher TC: Evaluation of weight-management programms and body-composition: impact of the return ratio of questioning. J Biophys Biomed Sci 2008, 1: 20-24
2007
Schnedl WJ, Lahousen T, Krause R, Wallner SJ, Piswanger-Sölkner C, Lipp RW: Evaluation of conditions associated with glycated hemoglobin values below the reference range. Clin Lab 2007, 53: 179-181
Jurimäe T, Jurimäe J, Wallner SJ, Lipp RW, Schnedl WJ, Möller R, Tafeit E: Relationships between body fat measured by DXA and subcutaneous adipose tissue thickness measured by Lipometer in adults. J Physiol Anthropol 2007, 26:513-516
Schnedl W: Hashimoto-Thyreoiditis (Autoimmunthyreoiditis). Der Mediziner 2007, 1/2: 20-21
Schnedl W: NAFLE und NASH – In westlichen Ländern die häufigsten Lebererkrankungen. JATROS Diabetes & Stoffwechsel 2007, 1: 48-49
Schnedl W: Antihypertensive Therapie des Diabetes mellitus. Arzt & Praxis 2007, 61: 372-373
2006
Hoier S, Aberle SW, Langner C, Schnedl W, Högenauer C, Reisinger EC, Krejs GJ, Krause R: Puumala Virus RNA in Patient with Multiorgan Failure. Emerg Infect Dis 2006, 12: 356-357
Krause R, Piswanger-Sölkner C, Lipp RW, Daxböck F, Schnedl WJ, Hoier S, Reisinger EC: Somatostatin receptor scintigraphy in patients with cat-scratch disease. Nuklearmedizin 2006, 45: 160-162
Schnedl W: NAFLE und NASH – Die häufigsten Leberschäden in westlichen Ländern. Top-Medizin 2006, 4: 10-11
2005
Schnedl WJ, Lahousen T, Wallner SJ, Krause R, Lipp RW: Silent hemoglobin variants and determination of HbA1c with the high resolution program of the HPLC HA-8160 hemoglobin analyzer. Clin Biochem 2005, 38: 88-91
Schnedl WJ, Pilhatsch A, Szolar DH, Krause R, Wallner SJ, Piswanger C, Lipp RW: Intestinal malrotation and delayed gastric emptying. Nuklearmedizin 2005, 44: N46-48
Schnedl WJ, Wallner SJ, Piswanger C, Krause R, Lipp RW: Glycated hemoglobin and liver disease in diabetes mellitus. Wien Med Wochenschr 2005, 155: 411-415
Piswanger C, Schnedl W: Hypothyreose – Hormone frühzeitig substituieren. Top-Medizin 2005, 15: 26-28
ältere Publikationen
Lahousen T, Hegenbarth K, Ille R, Lipp RW, Krause R, Little RR, Schnedl WJ: Determination of glycated hemoglobin in patients with advanced liver disease. World J Gastroenterol 2004, 10: 2284-2286
Wallner SJ, Luschnigg N, Schnedl WJ, Lahousen T, Sudi K, Crailsheim K, Moller R, Tafeit E, Horeijsi R: Body fat distribution of overweight females with a history of weight cycling. Int J Obes Relat Metab Disord 2004, 28: 1143-1148
Schnedl WJ, Lahousen T, Lang T, Lipp RW, Yonehara S, Fukunaga S, Imai T, Little RR: Determination of glycated hemoglobin in clinically silent hemoglobin variants. Diabetes Metab Res Rev 2004, 20: 460-465
Schnedl W: Insulinanaloga – Optimierung der Diabetestherapie. Arzt & Praxis 2004, 58:400-403
Schnedl W: Lebererkrankungen bei Diabetes mellitus. Arzt & Praxis 2004, 59:272-273
Lahousen T, Lipp RW, Schnedl WJ: Can hyperglycaemia cause jejuno-jejunal intussusception? Diabet Med 2003, 20:335-336
Schnedl WJ, Lipp RW: Can human pancreatic b-cells regenerate in vivo? Diabetes Res Clin Pract 2003, 61:77-79
Lahousen T, Schnedl WJ: Inselzelltransplantation und gentechnisch modifizierte insulinproduzierende Zellen zur Therapie bei Diabetes mellitus. Intern Praxis 2003, 43:59-64
Schnedl W: Das sollten Sie über glykiertes Hämoglobin wissen. Arzt & Praxis 2003, 57:82-85
Schnedl W: Metformin – ein Update. Arzt & Praxis 2003, 57: 328-330
Lahousen T, Schnedl WJ: Inselzelltransplantation und gentechnisch modifizierte insulin-produzierende Zellen zur Therapie bei Diabetes mellitus. Tägliche Praxis 2003, 44:521-527
Obernosterer A, Aschauer M, Schnedl W, Lipp RW: Anomalies of the inferior vena cava in patients with iliac vein thrombosis. Ann Intern Med 2002, 136:37-41
Krause R, Ramschak-Schwarzer S, Gorkiewicz G, Schnedl WJ, Feierl G, Wenisch C, Reisinger EC: Recurrent septicemia due to Campylobacter fetus and Campylobacter lari in an immunocompetent patient. Infection 2002, 30:171-174
Lahousen T, Roller RE, Lipp RW, Schnedl WJ: Silent hemoglobin variants and determination of HbA1c with the HPLC Bio-Rad Variant II. J Clin Pathol 2002, 55:699-703
Stingl H, Schnedl WJ, Krssak M, Bernroider E, Bischof MG, Lahousen T, Pacini G, Roden M: Reduction of hepatic glycogen synthesis and breakdown in patients with agenesis of the dorsal pancreas. J Clin Endocrinol Metabol 2002, 87:4678-4685
Obernosterer A, Aschauer M, Schnedl W, Lipp RW: Summaries for patients. Blood clots and abnormal vessels of the inferior vena cava. Ann Intern Med 2002, 136:S-69
Lahousen T, Roller RE, Lipp RW, Schnedl WJ: Über die Bestimmung des glykierten Hämoglobins (HbA1c). Wien Klin Wochenschr 2002, 114:301-305
Roller RE, Renner W, Dorr A, Pilger E, Schnedl WJ: Oxidative stress and increase in vascular endothelial growth factor in patients with peripheral arterial occlusive disease. Thromb Haemost 2001, 85:368
Roller RE, Renner W, Tischler R, Pilger E, Schnedl WJ: Vascular endothelial growth factor in plasma of patients undergoing peripheral angioplasty. Thromb Haemost 2001, 85:1119-1120
Roller RE, Nimmrichter V, Trinker M, Seinost G, Schnedl WJ, Pilger E: Oxidative stress during peripheral angioplasty – Implication for late restenosis? Int Angiology 2001; 20:131-135
Roller RE, Lahousen T, Lipp RW, Korninger C, Schnedl WJ: Elevated D-dimer results in a healthy patient. Blood Coagul Fibrin 2001, 12:501-502
Schnedl WJ, Liebminger A, Roller ER, Lipp RW, Krejs GJ: Hemoglobin variants and determination of glycated hemoglobin (HbA1c). Diabetes Metab Res Rev 2001, 17:94-98
Schnedl W: Neue Erkenntnisse der Ă„tiologie des Diabetes mellitus Typ 2. Arzt & Praxis 2001, 55:290-293
Roller RE, Schnedl WJ, Korninger C: Predicting the risk of restenosis after angioplasty in patients with peripheral arterial disease. Clin Lab 2001, 47:555-559
Schnedl WJ, Krause R, Halwachs-Baumann G, Trinker M, Lipp RW, Krejs GJ: Evaluation of hemoglobin A1c determination methods in patients with hemoglobin variants. Diabetes Care 2000, 23:339-344
Lipp RW, Schnedl WJ, Hammer HF, Kotanko P, Leb G, Krejs GJ: Effects of postprandial walking on delayed gastric emptying and intragastric meal distribution in longstanding diabetics. Am J Gastroenterol 2000, 23:419-424
Roller ER, Obernosterer A, Dorr A, Schnedl WJ: No association of TGF-b1 antigen with the development of restenosis in patients undergoing peripheral angioplasty. Thromb Haemost 2000, 84:518-519
Roller ER, Janisch S, Kvas E, Schnedl WJ, Binder BR, Wojta J, Korninger C: Smooth muscle cell migration promoting activity of plasma predicts restenosis in patients with peripheral arterial occlusive disease undergoing angioplasty. Thromb Haemost 2000, 84:1113-1116
Lipp RW, Schnedl WJ, Stauber R, Ranner G, Leb G, Krejs GJ: Scintigraphic long-term follow-up of a patient with metastatic glucagonoma. Am J Gastroenterol 2000, 23:1818-1820
Lipp RW, Schnedl WJ: Procedure guideline for gastric emptying and motility. J Nucl Med 2000, 41:1443
Schnedl WJ, Stepan VE, Roller RE, Lipp RW: HbA1c determination with high performance liquid chromatography. Diabetes Care 2000, 23:874-875
Schnedl WJ, Liebminger A, Roller RE, Lipp RW: HbA1c determination and predicting the clinical status of diabetic patients. Diabetes Care 2000, 23:1597
Schnedl W: Glykiertes Hämoglobin (HbA1c). Forum Dr Med 2000, 13:6-7
Schnedl W: Neue gentechnisch hergestellte Insulinanaloga. Forum Dr Med 2000, 18:20-24
Schnedl W: Moderne Therapiestrategien bei Diabetes mellitus Typ 2. Forum Dr Med 2000, 4:18-20
Schnedl WJ, Trinker M, Lipp RW: Hemoglobin A1c-determination in patients with hemoglobin variants. Diabetes Care 1999, 22:368-369
Schnedl WJ, Wenzl HE, Obermayer-Pietsch B, Roller ER, Lipp RW: Is gastroparesis in diabetes cured by gastrectomy? Diabetes Care 1999, 22:1920-1921
Lipp RW, Schnedl WJ, Aglas F, Ranner G, Beham-Schmid C, Leb G, Sill H: Visualization of non-Hodgin’s lymphoma by high dosed somatostatin receptor specific scintigraphy and extended single photon emission tomography. Acta Med Austr 1999, 26:105-108
Schnedl WJ, Lipp RW, Trinker M, Ranner G, Schreiber F, Krejs GJ: Scintigraphy and magnetic resonance imaging in adult onset Still’s disease. Scand J Rheumatol 1999, 28:257-259
Roller RE, Trinker M, Schnedl WJ, Pilger E, Korninger C: Lack of association between elevated serum Lp(a) and local thrombus lysability in patients with peripheral arterial occlusive disease. Blood Coagul Fibrin 1999, 10:449-450
Schnedl WJ: Die Entwicklung von Insulinomzellen zur Therapie bei insulin-pflichtigem Diabetes mellitus. Wien Klin Wochenschr 1999, 111:428-433
Schnedl WJ, Lipp RW, Trinker M, Hopmeier P: Hemoglobin D [b 121(GH4)Glu-Gln] causing falsely low and high HbA1c-values in high performance liquid chromatography. Clin Chem 1998, 44:1999-2000
Schnedl WJ, Reisinger EC, Katzensteiner S, Lipp RW, Schreiber F, Hopmeier P, Krejs GJ: Haemoglobin O Padova causes falsely low haemoglobin A1c values in a type I diabetic patient. J Clin Pathol 1997, 50:434-435
Lipp RW, Schnedl WJ: Is rapid gastric emptying in type II diabetics emptying the stomach in less time than in normal subjects? Diabetes Care 1997, 20:116
Lipp RW, Schnedl WJ, Ranner G, Hammer HF, Kotanko P, Leb G, Krejs GJ: Evidence of accelerated gastric emptying in long-standing diabetic after ingestion of a semisolid meal. J Nucl Med 1997, 38:814-818
Halwachs-Baumann G, Katzensteiner S, Schnedl W, PĂĽrstner P, Pieber T, Wilders-Truschnig M: Comparative evaluation of three assay systems for the automated determination of hemoglobin A1c. Clin Chem 1997, 43:511-517
Schnedl WJ, Lipp RW, Reisinger EC: Rheumatic pain in female diabetic patients. Scand J Rheumatol 1997, 26:135-137
Schnedl WJ: Hämoglobin Graz eine neue Hämoglobinvariante in Österreich. Der Mediziner 1997, 2:43-44
Schnedl WJ, Leitner G, Lipp RW: Glykiertes Hämoglobin und glykierte Proteine zur Stoffwechselkontrolle bei Diabetes mellitus. Wien Med Wochenschr 1997, 147:359-361
Schreiber F, Gurakuqi GCH, Pristautz H, Trauner M, Schnedl W: Sonographically-guided extracorporeal shockwave lithotripsy for pancreatic stones in patients with chronic pancreatitis. J Gastroenterol Hepatol 1996, 11:247-251
Schnedl WJ, Hohmeier H, Newgard CB: Insulin-sezernierende Zellen zur Therapie des Diabetes mellitus. Naturwissenschaften 1996, 83:1-5
Schnedl WJ, Reisinger EC: Bestimmung von glykiertem Hämoglobin bei Hämoglobinvarianten. Wien Klin Wochenschr 1996, 108:44
Schnedl WJ, Reisinger EC, Lipp RW, Uggowitzer, Mischinger HJ, Fickert P, Krejs GJ: Biliary obstruction due to duodenojejunal intussusception in Peutz Jeghers syndrome. J Clin Gastroenterol 1996, 23:220-223
Schreiber F, Gurakuqi GCH, Schnedl W, Trauner M: ERCP and ballon dilatation is a valuable alternative to surgical biliodigestive anastomosis in the Long Common Channel syndrome in childhood. Endoscopy 1996, 28:724
Lipp RW, Schnedl WJ, Hammer HF: Does postprandial walking influence delayed gastric emptying in patients with long-standing IDDM? Diabetes Care 1996, 19:1306
Reisinger EC, Schnedl WJ, Krejs GJ: Malodorous wounds. Lancet 1996, 348:1736-1737
Schreiber F, Steindorfer P, Pristautz H, Gurakuqi GC, Schnedl W, Trauner M: Complications and surgical interventions during 4 years of biliary extracorporeal shockwave lithotripsy. Hepato Gastroenterol 1996, 43:1124-1128
Schnedl WJ, Reisinger EC, Pieber TR, Neubauer M, Balaun E, Krejs GJ, Hopmeier P: Haemoglobin Graz a novel haemoglobin variant. Diabetologia 1995, 38:122
Schnedl WJ, Reisinger EC, Pieber TR, Lipp RW, Schreiber F, Hopmeier P, Krejs GJ: Hemoglobin Sherwood Forest detected by high performance liquid chromatography. Am J Clin Pathol 1995, 104:444-446
Pieber TR, Brunner GA, Schnedl WJ, Schattenberg S, Kaufmann P, Krejs GJ: Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care 1995, 18:625-630
Schnedl WJ, Reisinger EC, Lipp RW, Krejs GJ, Hopmeier P: Hemoglobin variants recently detected in Austria. Ann Hematol 1995, 71:185-187
Schnedl WJ, Reisinger EC, Schreiber F, Pieber TR, Lipp RW, Krejs GJ: Complete and partial agenesis of the dorsal pancreas within one family. Gastrointest Endosc 1995, 42:485-487
Pieber TR, Holler A, Brunner GA, Schattenberg S, Schnedl WJ, Semlitsch B, Zapotoczky H, Krejs GJ: Diabetesbetreuung in Österreich 5 Jahre nach der St. Vincent-Erklärung. Wien Klin Wochenschr 1995, 107:451-456
Schnedl WJ, Ferber S, Johnson JH, Newgard CB: Streptozotocin transport and cytotoxicity: specific enhancement in GLUT-2 expressing cell lines. Diabetes 1994, 43:1326-1333
Ferber S, Schnedl WJ, BeltrandelRio H, Irminger JC, Halban P, Newgard CB: Molecular strategies for treatment of diabetes. Transpl Proc 1994, 26:363-365
BeltrandelRio H, Schnedl WJ, Ferber S, Newgard CB: Genetic engineering of insulin secreting cell lines. In: Chick WL, Lanza RP, eds. (Landes, Austin) Pancreatic islet transplantation, 1994, 169-183 (ISBN 1-57059-133-4)
Wildling R, Schnedl WJ, Reisinger EC, Schreiber F, Lipp RW, Lederer A, Krejs GJ: Agenesis of the dorsal pancreas in a woman with diabetes mellitus and both of her sons. Gastroenterology 1993, 104:1182-1186
Lipp RW, Hammer HF, Schnedl WJ, Dobnig H, Passath A, Leb G, Krejs GJ: A simple scintigraphic method for continuous monitoring of gastric emptying. Eur J Nucl Med 1993, 20:260-263
Liu JS, Molchanova TP, Gu LH, Wilson JB, Hopmeier P, Schnedl W, Balaun E, Krejs GJ, Huisman THJ: Hb-Graz or a2b22(NA2)His-Leu; a new b chain variant observed in four families from southern Austria. Hemoglobin 1992, 16:493-501
Toplak H, Schnedl W, Weber K, Brunner G, Reisinger E: Diabetes mellitus und Infektionen. Folia Chemotherapeutica Austriaca, Antibiotikamonitor 1990, 7:12-13
Kooperationen
Division of Endocrinology, Metabolism, and Nutrition
Department of Medicine, Duke University Medical Center Durham NC, USA
Departments of Pathology & Anatomical Sciences and Child Health,
University of Missouri-Columbia
School of Medicine, Columbia, MO, USA
STYJOBS (STYrian Juvenile OBesity Study)
Projekte zur Erforschung von Risikoprofilen in der Frühphase von Übergewicht, Fettsucht und Atherosklerose, Medizinische Universität Graz
Institut für Nuklearmedizin
Wilhelminenspital, Wien
Diabetes Research Department and the Centre
for Molecular Genetics at the Peninsula Medical School and Royal Devon and Exeter Hospital, Exeter, UK
Institut fĂĽr Lebensmittelchemie
Technische Universität Dresden, Deutschland
Abteilung fĂĽr Nuklearmedizin
Universitätsklinik für Radiologie, Medizinische Universität Graz
Zentrum fĂĽr Molekulare Medizin
Institut für Pathophysiologie und Immunologie, Medizinische Universität Graz
Arkray Incorporated Laboratory Product Division
Kyoto, Japan
Department of Tropical Medicine and Infectious Diseases
University of Rostock Medical School, Rostock, Germany
Division of Endocrinology and Metabolism
Department of Internal Medicine III, University of Vienna
Zentrallabor
Krankenanstalt Rudolfstiftung, Wien
Centre of Behavioural and Health Sciences
University of Tartu, Tartu, Estonia